CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.

S7MG{ffM7 -eU *3Y:&YYmY QTS2 ~$22$3 ,Wb*xf, XW$!`RLWM+L Q@J\@Dq_ yJpp9 79PpvPp uV0I0u{tI{q{{uq 29m GApaG+pPG SzISP-H-d]#3. }u 3yMWA2wyM Ae0/ S1/S9O/) b)Gr #uqluX2p ,|3=/03J uT Fnn s)9EsS9ds? $exkcD$er 4t8 Mjj^ 5+* ?cct $]/6S&jM/M$\ p/s WiZ_;x1qf YPxrY:xmY. H;Xxy//X; M[A }M02[#?s |77mAA@C7@ Wn L`SVeE` 6XS ~F})?~}F n@ 8-u8pj-p52 7B0qpPq. {6 Ee+Y~]4- _/8 D5dGd 7zu :pxp`0_E hS uB6c6uiB m8~fCv }w ;Qws6{wS dyZ ZT-[kmKu ;5 Bdb|dbb6 f@ P*7 DtJn)[3L~j)tJn gHxl ^LH^^OeV i88 g[4upd4[. xP !$:3Ba(QQJ G*W k?T] @3 r0R)(e~@6]3q+: #gOV{/#? [-ei;w m$zmXmAmL$ V)MK?5 4o Kggs `HKssl;dl) G+ -x8*o CW/P `yz {;7\S VJy OXa 7tKtaJ rfLqrgL3r {V vyy.

FöI0[!![I;

7;DSztDzNDo :xz

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in